ACUTA CAPITAL PARTNERS, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 77 filers reported holding RELMADA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$20,939,000
+212.8%
565,618
+60.5%
9.02%
+141.8%
Q2 2022$6,694,000
-27.5%
352,500
+3.1%
3.73%
-13.5%
Q1 2022$9,231,000
+1.4%
342,000
-15.3%
4.31%
+12.7%
Q4 2021$9,102,000
+136.5%
404,000
+236.7%
3.83%
+265.4%
Q4 2020$3,848,000
-63.1%
120,000
-56.7%
1.05%
-63.0%
Q3 2020$10,421,000
-0.7%
277,000
+18.1%
2.83%
-6.7%
Q2 2020$10,494,000
+238.3%
234,500
+157.8%
3.03%
+101.6%
Q1 2020$3,102,00090,9501.50%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders